Treatment Algorithms 2002: Hepatitis B and C

Treatment Algorithm 2002:Hepatitis B and C is an analysis of the treatment patterns of hepatitis B (HBV) and hepatitis C (HCV) infection, in seven of the worlds major markets, namely the US, Japan, France, Germany, Italy Spain and the UK. The report is based on extensive primary physician research across these regions, and validated through secondary research, with NGOs, government agencies and clinical and research journals. Structure of report: The report is broken down into 4 sections, as described below: * Clinical overview - Complete epidemiological analysis, by incidence and prevalence for the seven major markets. The patient group is analyzed and split by diagnosis and treatment. * Presentation, Screening and Diagnosis - provides a breakdown of physician types involved in presentation, diagnosis and treatment. Screening programs and diagnostic guidelines are analyzed for each country. * Global Treatment patterns - Breakdown of patient share between first line therapy treatment, including dosage amount, frequency and length of therapy. Response and relapse rates to each therapy are provided, along with a further breakdown of second line treatment. Analysis of global treatment patterns and variations are followed by a more in depth view of each of the seven major markets. * Analyst insight - The key impacts on future treatment of HBV and HCV, both from a physician perspective, and from Datamonitors viewpoint. Unmet needs in the treatment of hepatitis are identified, and the health economics of both diseases are discussed, specifically the growth of the diseased population in the major markets, the impact of vaccination on the progression of HBV disease, the increasing significance of HIV comorbidity and the prospective for prophylactic and therapeutic vaccine development for HCV infection.